https://mavengity.com/articles/healthcare-medical/novartis-halts-vhb937-als-trem2/ Mavengity en 2026-09-17T18:35:52+02:00 Novartis Halted Its ALS Drug After the Biomarkers Moved and the Patients Did Not https://mavengity.com/articles/healthcare-medical/fda-testosterone-women-review-workshop/ Mavengity en 2026-09-17T18:35:47+02:00 Testosterone Prescriptions for Women Nearly Tripled While the FDA Had No Approved Product. The Review Just Opened https://mavengity.com/articles/mortgage/30-year-mortgage-6-95-percent-after-fed-hike/ Mavengity en 2026-09-17T18:35:43+02:00 The 30-Year Mortgage Jumped to 6.95 Percent in the Week the Fed Hiked https://mavengity.com/articles/mortgage/danish-5-percent-mortgage-loan-opens/ Mavengity en 2026-09-17T15:40:22+02:00 Denmark Opened Its First 5 Percent Mortgage Since 2023, and the Fed Hike Helped Push It Open https://mavengity.com/articles/legal/oregon-covid-fraud-recovery-314-million/ Mavengity en 2026-09-17T15:40:18+02:00 Oregon's COVID Fraud Prosecutors Have Recovered 22 Cents on Every Stolen Dollar https://mavengity.com/articles/healthcare-medical/blinatumomab-replaces-chemotherapy-childhood-leukemia/ Mavengity en 2026-09-17T15:40:13+02:00 A Childhood Leukemia Trial Just Replaced Chemotherapy Instead of Adding to It https://mavengity.com/articles/legal/wisconsin-supreme-court-hears-congressional-maps/ Mavengity en 2026-09-17T12:55:00+02:00 The Wisconsin Maps Fight Is Really About a Doctrine Called Least Change https://mavengity.com/articles/healthcare-medical/saphier-vaccines-measles-senate-hearing/ Mavengity en 2026-09-17T12:54:55+02:00 The Surgeon General Nominee Defended the MMR Vaccine, and the Senate Wanted More Than Belief https://mavengity.com/articles/legal/google-ad-tech-monitor-six-year-decree/ Mavengity en 2026-09-17T12:54:51+02:00 The Google Ad Tech Remedy Is Now a Monitor the Company Pays For https://mavengity.com/articles/healthcare-medical/dartmouth-health-cuts-427-jobs/ Mavengity en 2026-09-17T12:54:47+02:00 Dartmouth Health Is Cutting the Management Layer, Not the Bedside https://mavengity.com/articles/healthcare-medical/cvs-criteo-20-million-settlement/ Mavengity en 2026-09-17T12:54:42+02:00 A $20.5 Million Settlement Put a Price on Pharmacy Website Tracking https://mavengity.com/articles/finance/csbs-ai-supervisory-framework/ Mavengity en 2026-09-17T12:54:38+02:00 The States Just Erased the $30 Billion Line in Bank AI Oversight https://mavengity.com/articles/healthcare-medical/cdc-children-covid-vaccine-orders-delayed/ Mavengity en 2026-09-17T12:54:34+02:00 Half of American Children Get Vaccines Through a Program That Cannot Order COVID Shots Yet https://mavengity.com/articles/legal/california-judge-limits-warrantless-immigration-arrests/ Mavengity en 2026-09-17T12:54:08+02:00 Southern California Immigration Arrests Now Require a Written Flight-Risk Finding https://mavengity.com/articles/finance/australian-banks-financial-abuse-guideline/ Mavengity en 2026-09-17T12:53:37+02:00 Australian Banks Put Safety-by-Design Into the Product Itself https://mavengity.com/articles/finance/fed-first-hike-since-2023-was-the-easy-part/ Mavengity en 2026-09-16T21:07:03+02:00 The Fed's First Hike Since 2023 Was the Easy Part https://mavengity.com/articles/healthcare-medical/medtronic-ligasure-hugo-clearance/ Mavengity en 2026-09-16T15:42:13+02:00 Medtronic Filled the Missing Piece in Its Robot Pitch https://mavengity.com/articles/healthcare-medical/trutakna-origin-3-final-analysis-igan/ Mavengity en 2026-09-16T14:33:01+02:00 Trutakna's Confirmatory Trial Delivered the Number the Label Was Missing https://mavengity.com/articles/healthcare-medical/ivonescimab-harmoni-os-wclc-2026/ Mavengity en 2026-09-16T14:32:57+02:00 Ivonescimab's Strongest Proof Is Half a World Away https://mavengity.com/articles/legal/paramount-wbd-settlement-talks-ticking-fee/ Mavengity en 2026-09-16T14:32:53+02:00 The Meter Is Running on the Paramount-Warner Bros. Deal https://mavengity.com/articles/finance/openai-1-2-trillion-valuation-burn-math/ Mavengity en 2026-09-16T14:32:48+02:00 OpenAI's $1.2 Trillion Number Comes With a $17 Billion Footnote https://mavengity.com/articles/finance/canada-productivity-mega-deduction-6-4-metr/ Mavengity en 2026-09-16T14:32:43+02:00 Canada's New Investment Pitch Is a Number: 6.4 Percent https://mavengity.com/articles/finance/clarity-act-cloture-fails-crypto-markets/ Mavengity en 2026-09-16T14:32:39+02:00 The Clarity Act Failed Before the Debate Started https://mavengity.com/articles/legal/mail-ballot-rule-scotus-timing-not-merits/ Mavengity en 2026-09-16T14:32:10+02:00 The Mail-Ballot Fight Was Lost on Timing, Not on the Merits https://mavengity.com/articles/mortgage/mba-new-jersey-disparate-impact-lawsuit/ Mavengity en 2026-09-15T21:41:32+02:00 The Mortgage Industry Sues New Jersey Over the Country's Broadest Lending Rule https://mavengity.com/articles/finance/aldermore-sale-nationwide-investec-bids/ Mavengity en 2026-09-15T21:41:28+02:00 A Challenger Bank Goes Up for Sale, and Its Best Feature Is a Legal Cloud https://mavengity.com/articles/finance/fin-com-stablecoin-last-mile-seed/ Mavengity en 2026-09-15T18:41:33+02:00 The Stablecoin Boom's Next Prize Is the Most Boring Mile https://mavengity.com/articles/healthcare-medical/gsk-chimagen-multiple-myeloma-deal/ Mavengity en 2026-09-15T18:41:28+02:00 GSK Bets Up to $750 Million That a Preclinical Drug Can Fix Blood Cancer Therapy's Hardest Problem